User profiles for Gary Leeming
Gary LeemingUniversity of Liverpool Verified email at liverpool.ac.uk Cited by 3361 |
[HTML][HTML] Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
…, J Harrison, L Marsh, M Connor, G Leeming… - The Lancet …, 2021 - thelancet.com
Background Prognostic models to predict the risk of clinical deterioration in acute COVID-19
cases are urgently required to inform clinical management decisions. Methods We …
cases are urgently required to inform clinical management decisions. Methods We …
[HTML][HTML] Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort …
Background Studies of patients admitted to hospital with COVID-19 have found varying
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid …
Blockchain in health care: hype, trust, and digital health
The promise of digital health care continues to be enthusiastically promoted but has been
difficult to realise. Evidence-based practice, along with patient safety assurances, information …
difficult to realise. Evidence-based practice, along with patient safety assurances, information …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…
The DynAIRx Project Protocol: Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity
…, A Griffiths, C Kullu, G Leeming… - Journal of …, 2022 - journals.sagepub.com
Background Structured Medication Reviews (SMRs) are intended to help deliver the NHS
Long Term Plan for medicines optimisation in people living with multiple long-term conditions …
Long Term Plan for medicines optimisation in people living with multiple long-term conditions …
[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
…, R Hendry, S Knight, E Lahnsteiner, G Leeming… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …
limited insights into mucosal defences that prevent viral replication and onward transmission. …
[HTML][HTML] Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective …
…, S Clohisey, R Hendry, G Leeming… - The Lancet …, 2021 - thelancet.com
Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
[HTML][HTML] A ledger of me: personalizing healthcare using blockchain technology
Personal Health Records (PHRs) have the potential to give patients fine-grained, personalized
and secure access to their own medical data and to enable self-management of care. …
and secure access to their own medical data and to enable self-management of care. …
[HTML][HTML] Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients. …
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients. …